CN1164273C - Natural oral liquor for treatment of women's climacteric syndrome - Google Patents
Natural oral liquor for treatment of women's climacteric syndrome Download PDFInfo
- Publication number
- CN1164273C CN1164273C CNB011268042A CN01126804A CN1164273C CN 1164273 C CN1164273 C CN 1164273C CN B011268042 A CNB011268042 A CN B011268042A CN 01126804 A CN01126804 A CN 01126804A CN 1164273 C CN1164273 C CN 1164273C
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- cosolvent
- women
- portions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides natural oral liquid for resisting female climacteric syndrome prepared by extracting effective components from plants, which is composed of the following components by the weight ratio: 1 to 3.5 portions of catechol, 2 to 9 portions of L-alanine, 2 to 4 portions of cimifugin, 1 to 4 portions of oleanic acid, 3 to 10 portions of genistein, 4 to 18 portions of quercetin, 2 to 6 portions of pantothen, dissolution assisting agent, spice and perfume. The oral liquid of the present invention has the functions of supplementing estrogen, regulating incretion, exciting the uterus, reducing blood fat, reducing blood sugar and inhibiting histamine release, especially the functions of improving the microcirculation of genitalia acra, enhancing immunity, clearing oxygen free radicals, resisting fatigue, etc. Thus, the oral liquid of the present invention can improve various unhealthy symptoms in the climacteric period of the female without the side effect produced by the ordinary use of hormones.
Description
Technical field
The present invention relates to a kind of natural oral liquid, relate in particular to a kind of natural oral liquid of treatment of women's climacteric syndrome.
Background technology
Usually the women enters into the climacteric period and can occur: 1. irregular menses and then stop ovary anovulation and secreting hormone; 2. estrogen reduces suddenly, sexual organ's atrophy; 3. vasoconstriction instability and property vaginitis bitterly, obstacle appears in sexual function; 4. upseting of flushing, dizzy, headache, cardiopalmus, not clear shape.According to traditional theory of medicine and treatment, it is in default of hormone that the women enters into the climacteric period, and most applications is to replenish the lutein hormone to the patient when treatment, and this can only allow the patient keep the eumenorrhea.And the women who enters into the climacteric period, what they need obtain effectively replenishing is to promote 17-hydroxy-11-dehydrocorticosterone, thyroxin and ovarian hormone.They need effectively be prevented and treated is microcirculation disturbance, hypertension, hyperlipidemia, hyperglycemia, the obesity that exceeds standard, immunity degradation and neural subhealth state.Simultaneously, should also be pointed out that if single excessive additional lutein hormone can increase the probability that the patient suffers from breast cancer.Over 50 years, American-European countries uses hormone in a large number, causes the European and American areas to become global breast carcinoma district occurred frequently, and this also is a undisputable fact.
In view of existing situation, the object of the present invention is to provide a kind of natural oral liquid that can effectively alleviate climacteric syndrome.
The natural oral liquid of treatment of women's climacteric syndrome of the present invention includes following raw material:
Catechol, L-arginine, cimifugin, oleanolic acid, genistein, Quercetin, pantothenic acid; Each raw material components mass ratio is:
Catechol 1-3.5: L-arginase 12-9: cimifugin 2-4: oleanolic acid 1-4: genistein 3-10: Quercetin 4-18: pantothenic acid 2-6.
Oral liquid of the present invention also includes cosolvent, and cosolvent includes glycerol, phospholipid, lemonade, and its constituent mass than (by 100% cubage) is: glycerol 1-9: phosphatidase 10 .9-9: lemonade 0.5-7.Its with the above-mentioned raw materials quality and ratio be 1-5: 1-3.
Oral liquid of the present invention also contains flavoring agent, and flavoring agent includes: Fructus Momordicae glucin, glycyrrhizin and dihydro hesperidin.Above-mentioned flavor ingredients mass ratio is: Fructus Momordicae glucin 2-9: glycyrrhizin 0.1-8: dihydro hesperidin 6-18.Its with cosolvent, raw materials quality and ratio be 0.1-1.3: 4-17.
The present invention also includes deodorant tune, its with the quality of above-mentioned cosolvent, flavouring agent and raw material and ratio be 0.01-1: 8-28.Deodorant tune of the present invention is silk wood chromone (Flindersiachromone).
Manufacture method of the present invention comprises the following steps:
With each material component mix homogeneously;
Preparation cosolvent, and the cosolvent for preparing is added in the raw material components of above-mentioned mix homogeneously in proportion, and make it uniform dissolution and make solution;
The preparation flavoring agent, and be added in the above-mentioned solution in proportion the flavoring agent for preparing and mix homogeneously;
Add deodorant tune.
Each raw material of the present invention is described as follows:
Catechol (Catechol) molecular formula: C
6H
6O
2Molecular weight: 110.11
Derive from: Herba Passiflorae Caeruleae flower, fruit ear (Passiflara Caerulea) Semen Vitis viniferae (Vitis Uinifera).
Active characteristics: excited intestinal of energy and uterus inwall smooth muscle have anticonvulsant action.Enter behind the human body and can comparatively fast change catecholamine, can prevent that nucleic acid denaturation and line graininess from being destroyed by hypotonic medium, and participate in the activation of steatolysis phosphorylase B, the equivalent journey of apologizing for having done sth. wrong of modification of protein hormones enzyme.
L-arginine (L-Arginine) molecular formula: C
6H
14N
4O
2Molecular weight: 174.21
Derive from: alfalfa (Medicago Satiua)
Active characteristics: the necessary material of infants growth and development.The hypophysis growth hormone releasing can be stimulated, blood ammonia levels can be reduced.
Cimifugin (Cimifugin) molecular formula: C
16H
18O
6Molecular weight: 306.32
Derive from: umbellifer Radix Saposhnikoviae rhizome, Ranunculaceae Rattleroot plant
Active characteristics: can quicken the heart coronaries blood flow, the analgesia of diaphoresis simultaneously, analgesic.
Oleanolic acid (oleanolic acid) (Oleanolic acid) molecular formula: C
30H
48O
3
Molecular weight: 456.71
Derive from: Oleaceae plant olive (Olea europaea L) Fructus Ligustri Lucidi fruit, Swertia mussotii Franch., Radix Betae.
Active characteristics: heart tonifying, blood sugar lowering, inhibition histamine release are to PGE
2, PGF
2Synthetic stimulation arranged, can induce CAMP content to increase, CGMP obviously descends.
Genistein (Genistein) molecular formula: C
15H
10O
5Molecular weight: 270.25
Derive from: leguminous plant dyewood (Flos Caraganae Sinicae) (Genista Cinctoria)
Active characteristics: estrogen effect, blood fat reducing be cholesterol and triglyceride in the blood particularly, and can suppress histidine decarboxylase.
Quercetin (quercetin) is molecular formula: C (Quercetin)
15H
10O
7Molecular weight: 302.25
Derive from: her Billy oak (Quercusiberica) of Fagaceae plant, Hunan Fructus Forsythiae herb (Hypericumascyron).
Active characteristics: strengthen the release action of capillary resistance, microcirculation improvement, blood fat reducing, anticoagulant and 5-hydroxy tryptamine, obviously reduce the flowability of platelet membrane lipid, suppress lipese and CAMP (3,5-ring gland purine nucleosides list phosphoric acid) phosphodiesterase.
Pantothenic acid (Pantothenic acid) molecular formula: C
9H
17NO
3Molecular weight: 219.24
Derive from: all contain in rice sugar, molasses and the fresh vegetables.Participate in the metabolism of protein, fat, sugar.Belong to vitamin B complex.
Active characteristics: participate in human body sugar, lipid metabolism activity and promote synthesizing of catechol amide etc.
Above-mentioned raw materials all extracts from natural plants.
The active ingredient of extracting from natural plants Semen sojae atricolor, alfalfa and molasses, genistein, L-arginine and pantothenic acid all are growth hormone, corticotropin, the precursor of thyroxin ovarian hormone, releasing factor and endocrine regulatory factor.The active ingredient catechol of from nontoxic, natural plants Semen Vitis viniferae, Radix Saposhnikoviae, Fructus Forsythiae and Radix Betae, extracting, cimifugin, Quercetin (quercetin) and oleanolic acid, strengthening microcirculation, blood fat reducing, blood sugar lowering, blood pressure lowering, calming the nerves and nourish heart, ease pain analgesic, removing oxygen-derived free radicals, there is special effectiveness the enhancing immunity aspect.These seven kinds mainly contain the effective constituent reciprocal causation, respectively execute monarch, minister, make duty, have both replenished the hormone of necessity, have prevented the mammary gland enlargement canceration that hormone may cause again, have both adjusted endocrine, vegetative nerve, have alleviated the various symptoms of climacteric syndrome again.Natral plant ingredients has complementing estrogen respectively, adjust endocrine, excited uterus, blood lipid-reducing blood sugar-decreasing, inhibition histamine release, calm the nerves nourish heart, microcirculation improvement functions such as genitals acra microcirculation, enhancing immunity, removing oxygen-derived free radicals, resisting fatigue particularly.Therefore, take oral liquid of the present invention, ill symptomses such as the agitation that Woman climacteric occurs, cardiopalmus, weak, uterus ovarian atrophy, vagina drying, inflammation pain, menstruation confusion are with alleviation and the recovery from illness that obtains in various degree.And effectively suppress and prevented issuable negative effect-increase breast carcinoma odds behind the enhancing estrogen.
Embodiment
Embodiment 1
(1) by following each raw material components of proportioning uniform mixing
The mass ratio of each raw material components is:
Catechol 1 L-arginase 12
Cimifugin 2 oleanolic acids 1
Genistein 3 Quercetins 4
Pantothenic acid 2
(2) in following ratio preparation cosolvent,
Each constituent mass ratio of cosolvent is: glycerol 1, phosphatidase 10 .9, lemonade 0.5.
The cosolvent for preparing is added in the raw material components of above-mentioned mix homogeneously by following proportioning, and makes it uniform dissolution and make solution.
Wherein cosolvent and raw material components quality and ratio be: 1: 1
(3) by following proportioning preparation flavoring agent
Each constituent mass ratio of flavoring agent is:
Fructus Momordicae glucin 3, glycyrrhizin 0.8, dihydro hesperidin 7
Be added in above-mentioned solution and mix homogeneously by following proportioning the flavoring agent for preparing, the ratio of the solution quality that flavoring agent and above-mentioned steps (2) make is 0.19: 4.6.
(4) add deodorant tune.
The solution quality ratio that deodorant tune and step (3) make is 0.01: 8.
By said ratio deodorant tune is added in the obtained solution of step (3), and mix homogeneously.
Embodiment 2
(1) by following each material component of proportioning uniform mixing
The mass ratio of each raw material components is:
Catechol 1.7 L-arginine 4
Cimifugin 3 oleanolic acids 3
Genistein 6 Quercetins 10
Pantothenic acid 3
(2) in following ratio preparation cosolvent,
Each constituent mass ratio of cosolvent is: glycerol 4, phosphatidase 15, lemonade 3.
The cosolvent for preparing is added in the raw material components of above-mentioned mix homogeneously by following proportioning, and makes it uniform dissolution and be modulated into solution.
Wherein cosolvent and raw material components quality and ratio be: 3: 2
(3) by following proportioning preparation flavoring agent
Each constituent mass ratio of flavoring agent is:
Fructus Momordicae glucin 5, glycyrrhizin 3, dihydro hesperidin 12
Be added in above-mentioned solution and mix homogeneously by following proportioning the flavoring agent for preparing, the ratio of the solution quality that flavoring agent and above-mentioned steps (2) make is 08: 9.8.
(4) add deodorant tune.
The solution quality ratio that deodorant tune and step (3) make is 0.13: 10.
By said ratio deodorant tune is added in the prepared solution of step (3), and mix homogeneously.
Embodiment 3
(1) by following each material component of proportioning uniform mixing
The mass ratio of each raw material components is:
Catechol 3.5 L-arginine 9
Cimifugin 4 oleanolic acids 4
Genistein 10 Quercetins 18
Pantothenic acid 6
(2) in following ratio preparation cosolvent,
Each constituent mass ratio of cosolvent is: glycerol 9, phospholipid 9, lemonade 7.
The cosolvent for preparing is added in the raw material components of above-mentioned mix homogeneously by following proportioning, and makes it uniform dissolution and be modulated into solution.
Wherein cosolvent and raw material components quality and ratio be: 5: 3
(3) by following mass ratio preparation flavoring agent
Each constituent mass ratio of flavoring agent is:
Fructus Momordicae glucin 8, glycyrrhizin 7, dihydro hesperidin 17
Be added in above-mentioned solution and mix homogeneously by following proportioning the flavoring agent for preparing, the mass ratio of the solution that flavoring agent and above-mentioned steps (2) make is 1.2: 15.
(4) add deodorant tune.
The solution quality ratio that deodorant tune and step (3) make is 1: 28.
By said ratio deodorant tune is added in the obtained solution of step (3), and mix homogeneously.
Claims (6)
1. the natural oral liquid of a treatment of women's climacteric syndrome includes following raw material:
Catechol, L-arginine, cimifugin, oleanolic acid, genistein, Quercetin, pantothenic acid; Each raw materials quality ratio is:
Catechol 1-3.5: L-arginase 12-9: cimifugin 2-4: oleanolic acid 1-4: genistein 3-10: Quercetin 4-18: pantothenic acid 2-6.
2. the natural oral liquid of a kind of treatment of women's climacteric syndrome according to claim 1 is characterized in that, also contains cosolvent, and cosolvent includes glycerol, phospholipid, lemonade; Each constituent mass ratio of cosolvent is: glycerol 1-9: phosphatidase 10 .9-9: lemonade 0.5-7; Its with the above-mentioned raw materials quality and ratio be 1-5: 1-3.
3. the natural oral liquid of a kind of treatment of women's climacteric syndrome according to claim 1 is characterized in that, also contains flavoring agent, and flavoring agent includes: Fructus Momordicae glucin, glycyrrhizin and dihydro hesperidin; Flavoring agent each component mass ratio is: Fructus Momordicae glucin 2-9: glycyrrhizin 0.1-8: dihydro hesperidin 6-18; Its ratio with cosolvent, raw materials quality sum is 0.1-1.3: 4-17.
4. the natural oral liquid of a kind of treatment of women's climacteric syndrome according to claim 1 is characterized in that, also contains deodorant tune, the quality of deodorant tune and raw material, cosolvent, flavouring agent and ratio be 0.01-1: 8-28.
5. according to the natural oral liquid of claim 1 or 4 described a kind of treatment of women's climacteric syndrome, it is characterized in that described deodorant tune is the silk wood chromone.
6. the manufacture method of the natural oral liquid of a kind of treatment of women's climacteric syndrome according to claim 1 comprises the following steps:
With each material component mix homogeneously;
Preparation cosolvent glycerol 1-9: phosphatidase 10 .9-9: lemonade 0.5-7, and the cosolvent for preparing is added in the raw material components of above-mentioned mix homogeneously in proportion, and make it dissolving and evenly make solution; The preparation flavoring agent, and be added in the above-mentioned solution in proportion the flavoring agent for preparing and mix homogeneously;
Add deodorant tune.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011268042A CN1164273C (en) | 2001-09-19 | 2001-09-19 | Natural oral liquor for treatment of women's climacteric syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011268042A CN1164273C (en) | 2001-09-19 | 2001-09-19 | Natural oral liquor for treatment of women's climacteric syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1404837A CN1404837A (en) | 2003-03-26 |
| CN1164273C true CN1164273C (en) | 2004-09-01 |
Family
ID=4666809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011268042A Expired - Fee Related CN1164273C (en) | 2001-09-19 | 2001-09-19 | Natural oral liquor for treatment of women's climacteric syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1164273C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101971988B (en) * | 2010-10-11 | 2012-05-23 | 孙羽蒙 | Prescription for treating female climacteric syndrome |
| CN105963246B (en) * | 2016-05-06 | 2018-12-25 | 荆楚理工学院 | A kind of genistein salt oral solution and preparation method and application |
| CN105853350A (en) * | 2016-05-24 | 2016-08-17 | 荆楚理工学院 | Genistein solution, preparation method and application |
-
2001
- 2001-09-19 CN CNB011268042A patent/CN1164273C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1404837A (en) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1958039A (en) | Preparation of Chinese traditional medicine for treating cardiovascular disease, and cerebrovascular disease | |
| CN1824155A (en) | Medicine used for kidney supplementing and its preparation method | |
| CN1813853A (en) | Chinese herbal medicine galactogogue for sow and its preparing method | |
| CN1899596A (en) | Chinese medicine preparation for preventing and controlling baldness and its preparing method | |
| CN1457848A (en) | Black-bone chicken white phoenix preparation medicine and its preparing method | |
| CN1297291C (en) | Medicine for abstaining from drug addiction and its preparation | |
| CN1220451C (en) | Health food | |
| CN1335177A (en) | Yang-strengthening and kidney-invigorating medicine and is prepn | |
| CN1164273C (en) | Natural oral liquor for treatment of women's climacteric syndrome | |
| CN1660196A (en) | Extractive of Chinese traditional medicine prepared from epimedium and drynaria, and method for producing preparation | |
| CN1899590A (en) | Gynecological Chinese patented medicine for relieving depressed liver and clearing heat, strengthening spleen and nourishing blood and its preparing method | |
| CN1150916C (en) | Fish medicine for preventing fish from raising nose above water | |
| CN1225273C (en) | Nutritious health care food and preparation prlcess thereof | |
| CN1290534A (en) | Quick-acting spray composition for proverting cold and its preparing method | |
| CN1593191A (en) | Pollen, bee milk food and its preparation method | |
| CN1899316A (en) | Chinese medicine micro emulsion preparation and its preparing method | |
| CN1119155C (en) | Chinese medicine composition for treating damaged skin | |
| CN1383868A (en) | Fleeceflower root tea | |
| CN106214908A (en) | A kind of obesity Chinese medicine external for the treatment of smears the preparation method of unguentum | |
| CN102579703B (en) | Product for improving male sexual function and preparation method thereof | |
| CN101036753A (en) | Health-care wine of Chinese traditional medicine and making method thereof | |
| CN1230512C (en) | Mud bath soap and its preparation method | |
| CN1432374A (en) | Kidney asthenia treating medicine and its prepn process | |
| CN1820642A (en) | Compound adzuki bean fat reducing medicinal food | |
| CN1299650A (en) | Oral capsule and paster for treating ischemic femur head necrosis and their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040901 Termination date: 20060919 |